Lipoprotein(a) in American Indians is low and not independently associated with cardiovascular disease: The Strong Heart Study

Annals of Epidemiology

Volumn 12, Issue 2, 2002, Pages 107-114

  Wang, Wenyu ^a   Hu, Dongsheng ^b,c   Lee, Elisa T ^a   Fabsitz, Richard R ^d   Welty, Thomas K ^e   Robbins, David C ^c   J L Yeh, ^a   Howard, Barbara V ^c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b ZHENGZHOU UNIVERSITY   (China)

^c MEDSTAR RESEARCH INSTITUTE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e Aberdeen Area Tribal Chairmen's Health Board   (United States)

Author keywords

American Indians; Cardiovascular disease; Cox regression model; Lipoprotein(a); The Strong Heart Study

Indexed keywords

APOLIPOPROTEIN B; FIBRINOGEN; GLUCOSE; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIABETES MELLITUS; DISEASE COURSE; ETHNOLOGY; FEMALE; GEOGRAPHIC DISTRIBUTION; GLUCOSE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGRESSION ANALYSIS;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; LIPOPROTEIN(A); LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 0036195964     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(01)00273-3     Document Type: Article

References (55)

1. A new serum type system in man: The Lp system
2. Physiochemical properties of apolipoprotein (a) and lipoprotein (a) derived from the dissociation of human plasma lipoprotein (a)
3. Lipoprotein (a) and diabetes mellitus
4. Lipoprotein (a), a cardiovascular risk factor: Importance of its determination in current clinical practice
5. Biologic markers as predictors of cardiovascular disease
6. Nontraditional cardiovascular risk factors
7. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study
8. Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Smivastatin Survival Study
9. Lp(a) lipoprotein is a major risk factor for cardiovascular disease: Pathogenic mechanisms and clinical significance
10. Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men
11. Predictive value of electrophoretically detected lipoprotein (a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women
12. Lp(a) in hypertensive patients
13. Lipoprotein (a) as a risk factor for ischemic heart disease: Metaanalysis of prospective studies
14. Lipoprotein (a) levels in relation to diabetic complications in patients with non-insulin-dependent diabetes
15. Association of elevated lipoprotein (a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein (a) phenotypes
16. Lipoprotein (a) as a risk factor for cardiovascular disease in elderly patients with diabetes
17. Lipoprotein (a) is an independent risk factor for coronary artery disease in NIDDM patients in South India
18. Lp(a) and the cardiovascular risk in dyslipidemia subjects
19. Lipoprotein (a) is a predictor for cardiovascular mortality of hemodialysis patients
20. Lipoprotein (a) as a risk factor for coronary heart disease in hemodialysis patients
21. Lipoprotein (a) displays increased accumulation compared with low-density lipoprotein in the murine arterial wall
22. Influence of lipoprotein (a) levels and isoforms on fibrinolytic activity-study in families with high lipoprotein (a) levels
23. Lipoprotein (a) levels and isoforms and fibrinolytic activity in postmenopause-influence of hormone replacement therapy
24. Concentrations of Lp(a) in black and white young adults: Relations to risk factors for cardiovascular disease
25. Lp(a) concentrates are related to plasma lipid concentrations
26. Lipoprotein (a) as cardiovascular risk in adult Mexicans
27. A prospective study of lipoprotein (a) and the risk of myocardial infarction
28. Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus
29. Cardiovascular disease and Lp(a) in the adult population and in the elderly: The Brisighella Study
30. Serum lipoprotein (a) and cardiovascular disease in non-insulin-dependent diabetes mellitus
31. Racial variation of cord plasma lipoprotein (a) levels in relation to coronary risk level: A study in three ethnic groups in Singapore
32. The Strong Heart Study. A study of cardiovascular disease in American Indians: Design and methods
33. Risk factors for coronary heart disease in diabetic and nondiabetic Native Americans: The Strong Heart Study
34. Cardiovascular disease risk factors among American Indians: The Strong Heart Study
35. Diabetes and impaired glucose tolerance in 3 American Indian populations aged 45 to 74 years: The Strong Heart Study
36. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus
37. All-cause mortality and cardiovascular disease mortality in 3 American Indian populations aged 45 to 74 years, 1984 to 88: The Strong Heart Study
38. Coronary heart disease prevalence and its relation to risk factors in American Indians: The Strong Heart Study
39. Parity, postmenopausal estrogen use, and cardiovascular disease risk factors in American Indian women: The Strong Heart Study
40. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography
41. Comparison of serum lipoprotein(a) distribution and its correlates among black and white populations
42. Isolation of apolipoprotein(a) from lipoprotein(a)
43. The mysteries of lipoprotein(a)
44. Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation
45. Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications
46. Lipoprotein(a) in diabetic patients with and without chronic renal failure
47. Serum lipoprotein(a) in patients with diabetes mellitus
48. Lp(a) concentrations in NIDDM
49. Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus
50. Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype
51. Effects for age, sex and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study
52. Plasma triglycerides and lipoprotein(a): Inverse relationship in a hyperlipidemic Italian population
53. Prevalence of lipoprotein(a) excess in coronary artery disease
54. Genetics of plasma lipoprotein(a) concentration
55. Plasma lipoprotein distribution of apolipoprotein(a) in the fed and fasted states